0
Intellia Therapeutics, Inc.
- 51-200 Employees
- Based in Cambridge, Massachusetts
Intellia Therapeutics, Inc., a gene editing company, focuses on the development of therapeutics utilizing a biological tool known as the CRISPR/Cas9 system. The company develops in vivo programs focused on liver diseases, including transthyretin amyloidosis, alpha-1 antitrypsin deficiency, hepatitis B virus, and inborn errors of metabolism programs. Its ex vivo pipeline includes proprietary…More
Intellia Therapeutics, Inc.
Most Recent Responsibility Report
Intellia Therapeutics, Inc. does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Intellia Therapeutics, Inc. Sustainability Report, Intellia Therapeutics, Inc. Corporate Social Responsibility Report, Intellia Therapeutics, Inc. CSR Report, Intellia Therapeutics, Inc. Corporate Responsibility, Intellia Therapeutics, Inc. CR Report, Intellia Therapeutics, Inc. Citizenship Report, Intellia Therapeutics, Inc. ESG Report, and Intellia Therapeutics, Inc. Environmental Report online.